AlphAIAlphAI — Financial news for AI agents
StockOTC · US · USDHealthcare · Drug Manufacturers - Specialty & Generic

$INIS

RADNOSTIX INC

Radnostix manufactures radioisotope-focused products for medical, industrial and research applications. Its five segments are Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The company produces and distributes radiopharmaceuticals, active pharmaceutical ingredients and radiochemicals; makes cobalt-60 sealed sources and recycles expended sources; and sells calibration and reference sources, imaging phantoms, shielding and related accessories. Its Medical Devices segment includes lung imaging products and distribution and servicing of radiosynthesis equipment. Fluorine Products produces fluoride gases, while the associated planned uranium de-conversion facility remains undeveloped. Radnostix sells directly to customers, including end users and distributors, and also sells products through distributors. Its customers include radiopharmacies, clinical research organizations, medical and research facilities, and industrial operators. The company is headquartered in Idaho Falls, Idaho.

Price · $INISvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $INIS in the last 7 days.

Insider · 30dAll trades →

No SEC Form 4 filings for $INIS in the last 30 days.

See all $INIS insider activity →
Top stories · $INISMore →
·prnewswire.comLow

Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI

Radnostix (OTCQB: INIS) and NANO Nuclear submitted a Letter of Intent to the NRC seeking consent for the transfer of License SUB-1011. This follows Lea County's approval of a property LOI. The transaction, expected to close in 90-120 days, involves $9.5M in cash and $4.0M in NANO stock. Radnostix aims to focus on radioisotope technologies post-sale.

·investing.com

Radnostix to sell nuclear fuel assets to NANO Nuclear for $13.5M

Radnostix Inc. (OTCQB:INIS) agreed to sell its nuclear fuel assets to NANO Nuclear Energy Inc. (NASDAQ:NNE) for $13.5M, including a $9.5M cash payment and $4M in NANO stock. The deal covers a U.S. NRC license and related tech. Closing is expected in 90-120 days, pending regulatory approvals. Radnostix plans to use proceeds for R&D in its radioisotope tech segments.

·tradingview.com

Radnostix to Sell DUF6 Plant Assets to Nano Nuclear for $9.5M Cash Plus $4M in Stock

Radnostix agreed to sell its DUF6 plant assets to Nano Nuclear Energy's subsidiary for $9.5M in cash and $4M in stock, pending regulatory approvals. The deal includes licenses, permits, and patents, with closing expected by September 28, 2026. Radnostix will use proceeds to refocus resources. (Source: SEC filing)

INIS sentiment & insider activity

Recent INIS coverage spans mergers & acquisitions and corporate actions.

What's driving INIS

  • The deal hinges on NRC consent; approval could boost Radnostix shares, while denial may depress them.

    prnewswire.com · Oct 19, 2026

  • The asset sale provides cash and stock to Radnostix, potentially supporting its R&D and product segments.

    investing.com · Oct 1, 2026

  • The asset sale provides modest cash but removes a planned uranium deconversion facility, likely leading to a slight downside pressure on the stock.

    tradingview.com · Oct 1, 2026

  • Potential share price pressure as the company exits a non‑core business and raises cash.

    SEC EDGAR 8-K · Oct 1, 2026

  • Equity plan approval can increase future dilution and signals ongoing incentive alignment, but the filing provides no new financial targets or operational change.

    SEC EDGAR 8-K · Jul 21, 2026

AlphAI scores every news story that mentions INIS with an AI model for sentiment and relevance, and aggregates insider trades from RADNOSTIX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $INIS

Score
$INISLowprnewswire.com

Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI

Radnostix (OTCQB: INIS) and NANO Nuclear submitted a Letter of Intent to the NRC seeking consent for the transfer of License SUB-1011. This follows Lea County's approval of a property LOI. The transaction, expected to close in 90-120 days, involves $9.5M in cash and $4.0M in NANO stock. Radnostix aims to focus on radioisotope technologies post-sale.

$INISMedinvesting.com

Radnostix to sell nuclear fuel assets to NANO Nuclear for $13.5M

Radnostix Inc. (OTCQB:INIS) agreed to sell its nuclear fuel assets to NANO Nuclear Energy Inc. (NASDAQ:NNE) for $13.5M, including a $9.5M cash payment and $4M in NANO stock. The deal covers a U.S. NRC license and related tech. Closing is expected in 90-120 days, pending regulatory approvals. Radnostix plans to use proceeds for R&D in its radioisotope tech segments.

$INISMedSEC EDGAR 8-K

RADNOSTIX INC (INIS): Entry into a Material Definitive Agreement

RADNOSTIX INC (INIS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear IDAHO FALLS, Idaho, October 1 st , 2026 — Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ( “Radnostix” or the “Company”) today announced that Radnostix and i

$INISLowSEC EDGAR 8-K

RADNOSTIX INC (INIS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

RADNOSTIX INC (INIS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. inis20260720_8k.htm false 0001038277 0001038277 2026-07-16 2026-07-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event repo

Related tickers

More in Drug Manufacturers - Specialty & Generic